Delve and the prescribing physician both assess suicidality.  Anyone assessed to be at high risk of suicide will be referred to a higher level of care, potentially to a setting that offers intravenous (IV) or Intermuscular injections (IM) Ketamine services with conjunctive psychotherapy.  Ketamine that is administered via IV or IM has data supporting decreasing suicidality.